Literature DB >> 11960601

Induction of G(2)/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T lymphocytes.

Silvia Villamarín1, Neus Ferrer-Miralles, Sylvia Mansilla, Waldemar Priebe, José Portugal.   

Abstract

WP631, a new DNA-binding drug that bisintercalates into DNA with high affinity, seems to be highly cytotoxic against Jurkat T lymphocytes. The purpose of this study was to gain new insights into the mechanisms by which WP631 halts proliferation in this cell type. Treating Jurkat cells with nanomolar concentrations of WP631 produced G(2)/M arrest, inhibited the transcription of c-myc and p53 genes, and induced limited apoptosis during the duration of treatment. Suppression of c-myc and p53 expression, and time-dependent decline in c-Myc and p53 protein levels, was associated with growth arrest. A weak interdependence was also found between the potent antiproliferative activity and the apoptotic response; treatment with WP631 for 24-36hr produced arrest in G(2)/M and allowed for partial DNA repair. Longer treatments with WP631 allowed some repaired cells to re-enter the cell cycle, but produced aneuploidy or apoptosis in others.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960601     DOI: 10.1016/s0006-2952(02)00865-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells.

Authors:  Kazuo Asanoma; Ge Liu; Takako Yamane; Yoko Miyanari; Tomoka Takao; Hiroshi Yagi; Tatsuhiro Ohgami; Akimasa Ichinoe; Kenzo Sonoda; Norio Wake; Kiyoko Kato
Journal:  Mol Cell Biol       Date:  2015-09-21       Impact factor: 4.272

2.  A new bisintercalating anthracycline with picomolar DNA binding affinity.

Authors:  José Portugal; Derek J Cashman; John O Trent; Neus Ferrer-Miralles; Teresa Przewloka; Izabela Fokt; Waldemar Priebe; Jonathan B Chaires
Journal:  J Med Chem       Date:  2005-12-29       Impact factor: 7.446

3.  Paclitaxel effects on the proteome of HL-60 promyelocytic leukemic cells: comparison to peloruside A.

Authors:  Anja Wilmes; Ariane Chan; Pisana Rawson; T William Jordan; John Holmes Miller
Journal:  Invest New Drugs       Date:  2010-09-23       Impact factor: 3.850

4.  c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells.

Authors:  Murali Gururajan; Roger Chui; Anbu K Karuppannan; Jiyuan Ke; C Darrell Jennings; Subbarao Bondada
Journal:  Blood       Date:  2005-05-12       Impact factor: 22.113

5.  Promoter-specific inhibition of transcription by daunorubicin in Saccharomyces cerevisiae.

Authors:  Silvia Marín; Sylvia Mansilla; Natàlia García-Reyero; Marta Rojas; José Portugal; Benjamin Piña
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

6.  Daunorubicin-induced variations in gene transcription: commitment to proliferation arrest, senescence and apoptosis.

Authors:  Sylvia Mansilla; Benjamin Piña; José Portugal
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

7.  Effects of the microtubule stabilizing agent peloruside A on the proteome of HL-60 cells.

Authors:  Anja Wilmes; Pisana Rawson; Lifeng Peng; Danyl McLauchlan; Peter T Northcote; T William Jordan; John H Miller
Journal:  Invest New Drugs       Date:  2010-01-27       Impact factor: 3.850

8.  Autophagy modulates the effects of bis-anthracycline WP631 on p53-deficient prostate cancer cells.

Authors:  Sylvia Mansilla; Carolina Vizcaíno; Maria A Rodríguez-Sánchez; Waldemar Priebe; José Portugal
Journal:  J Cell Mol Med       Date:  2015-02-16       Impact factor: 5.310

Review 9.  Two drugs are better than one. A short history of combined therapy of ovarian cancer.

Authors:  Barbara Bukowska; Arkadiusz Gajek; Agnieszka Marczak
Journal:  Contemp Oncol (Pozn)       Date:  2014-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.